Propanc Biopharma, Inc. (PPCB) › Total LiabilitiesPropanc Biopharma, Inc. (PPCB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $306.8K2012: $584.2K2019: $4.40M2020: $3.74M2021: $3.08M2022: $3.11M2023: $3.18M2024: $3.85M2025: $5.73M$5.73M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$5.73M+48.7%2024$3.85M+21.2%2023$3.18M+2.3%2022$3.11M+0.8%2021$3.08M-17.6%2020$3.74M-15.1%2019$4.40M—2012$584.2K+90.4%2011$306.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share